Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT01124240

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT…

Cilengitide 2000 mg flat i.v. twice weekly is administered over a period of 18 months without interruption. Starting one week after the initiation of Cilengiti…

Australia48 participantsStarted 2009-11

Treatment: Cilengitide